首页> 外国专利> Method for producing animal model for heart failure test causing left ventricular diastolic disorder and method for testing drug for treating heart failure due to left ventricular diastolic failure using said animal model

Method for producing animal model for heart failure test causing left ventricular diastolic disorder and method for testing drug for treating heart failure due to left ventricular diastolic failure using said animal model

机译:用于产生引起左心室舒张功能障碍的心力衰竭试验的动物模型的生产方法以及使用该动物模型的用于治疗由于左心室舒张衰竭的心力衰竭的药物的测试方法

摘要

An animal model capable of performing a drug efficacy test for left ventricular myocardial dysfunction, for example, heart failure due to left ventricular diastolic dysfunction is provided. Inject an aqueous solution of calcium chloride into the vein of an anesthetized small laboratory animal, and continue to inject the aqueous solution of calcium chloride into the vein, injecting an aqueous solution of norepinephrine into the vein to expand the left ventricle of the animal's heart. A method for producing an animal model for testing a therapeutic agent for heart failure that causes left ventricular diastolic dysfunction characterized by increasing the end-stage pressure to a level higher than the normal left ventricular end-diastolic pressure, and the therapeutic agent for heart failure produced by this method Intravenous norepinephrine aqueous solution is injected into the vein of the test animal model to measure left ventricular end diastolic pressure, and the measured left ventricular end diastolic pressure is compared with normal left ventricular end diastolic pressure before infusion of norepinephrine aqueous solution There is a method for testing a therapeutic agent for heart failure caused by left ventricular diastolic dysfunction using an animal model for heart failure testing in which left ventricular diastolic disorder has occurred.
机译:提供了一种能够对左心室心肌功能障碍例如因左心室舒张功能障碍引起的心力衰竭进行药物功效测试的动物模型。向麻醉的小型实验动物的静脉中注入氯化钙水溶液,然后继续向静脉中注入氯化钙水溶液,向血管中注入去甲肾上腺素水溶液,以扩大动物心脏的左心室。一种用于生产动物模型的方法,所述动物模型用于测试导致左心室舒张功能障碍的心力衰竭治疗剂,其特征在于将终末期压力升高至高于正常的左心室舒张末期血压的水平,以及心力衰竭治疗剂用这种方法生产的静脉去甲肾上腺素水溶液被注入被测动物模型的静脉中以测量左心室舒张末期压力,并且在注入去甲肾上腺素水溶液之前将测得的左心室舒张末期压力与正常的左心室舒张末期压力进行比较。本发明是一种使用已经发生左心室舒张功能障碍的心力衰竭试验动物模型来测试由左心室舒张功能障碍引起的心力衰竭治疗剂的方法。

著录项

  • 公开/公告号JPWO2005104833A1

    专利类型

  • 公开/公告日2008-03-13

    原文格式PDF

  • 申请/专利权人 株式会社アエタスファルマ;

    申请/专利号JP20060512875

  • 发明设计人 金子 昇;

    申请日2005-04-28

  • 分类号A01K67;

  • 国家 JP

  • 入库时间 2022-08-21 20:17:10

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号